ESR1 and neoplasm: ERα is well documented for its role in promoting estrogen-dependent breast tumorigenesis, whereas ERβ has been reported to inhibit tumor growth in multiple cancer types including breast and ovarian cancers, melanoma, and glioma [1–7].